We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Katarzyna
Campbell
+44 (0) 115 74 84 508
kasia.campbell@nottingham.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Smoking in pregnancy
This information is provided directly by researchers and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information.
Nicotine replacement therapy (NRT) provides nicotine without the toxins contained in cigarette smoke. When used with specialist support, it helps pregnant women stop smoking. The NRT instruction booklet includes use for preloading, reduction and lapse recovery; studies suggest that allowing people to smoke and use NRT together helps with stopping. Currently, NHS stop smoking support advises pregnant women not to smoke when using NRT. This study will test whether relaxing this message could help pregnant women to quit and improve babies’ health. The aim of this study is to test support for the following three uses of NRT:
1. Preloading - using nicotine patches for a short time when still smoking but preparing to stop
2. NRT in ‘slip ups’ (smoking occasional cigarettes) – advice to keep on with NRT during short ‘slip ups’; this may help them stop smoking for good
3. For women who cannot quit, using NRT to smoke less – this could also help them stop smoking; if not, breathing in less harmful cigarette smoke should make babies healthier
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
Current inclusion criteria as of 08/03/2022:
Women of any age who:
1. Are <25 weeks’ gestation and have been referred for or have received or attended an intment as part of standard antenatal care
2. Smoke ≥ 5 daily cigarettes
3. Willing to set a quit date and accept referral to SSS
4. Willing to use NRT patch to try to stop smoking
5. Able to understand written and spoken English
6. Able
You may not be able to take part if:
Current exclusion criteria as of 21/11/2023:1. Already in a cessation study2. Contraindications to NRT including: known severe reaction/hypersensitivity to NRT, recent cardiovascular/cerebrovascular event or changes and taking theophylline/clozapine3. Currently uses e-cigarette every day or more frequently
Previous exclusion criteria:1. Already in a cessation study2. Currently uses e-cigarettes daily or more frequently 3. Contraindications to NRT including: severe cardiovascular disease, unstable angina, cardiac arrhythmias, recent cerebrovascular accident or transient ischaemic attack (TIA), chronic, generalized skin disorders or sensitivity to nicotine patches, chemical dependence/alcohol addiction or major fetal anomalies4. Not able to read or understand text written in English
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Katarzyna
Campbell
+44 (0) 115 74 84 508
kasia.campbell@nottingham.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Nottingham and funded by NIHR Evaluation, Trials and Studies Co-ordinating Centre (NETSCC); Grant Codes: NIHR129210.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 49947
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
